The unique role of Ces3 in PPAR-mediated thermogenesis

Ces3 在 PPAR 介导的生热作用中的独特作用

基本信息

  • 批准号:
    10246563
  • 负责人:
  • 金额:
    $ 23.4万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2020
  • 资助国家:
    美国
  • 起止时间:
    2020-09-10 至 2021-09-09
  • 项目状态:
    已结题

项目摘要

Lipid droplets (LDs) are cytosolic organelles that serve as the major energy reservoir in most cell types. Excessive accumulation of neutral lipids in LDs of adipose tissue has been linked to obesity and obesity-associated metabolic disorders. LDs are dynamically forming, enlarging as well as shrinking and the dynamics is regulated by multiple proteins bound to their surfaces. Recently, we identified Carboxylesterase 3 (Ces3) that translocates onto the surface of LDs in response to β-adrenergic signaling-stimulation. We showed that blockage of Ces3 on LDs led to not only decreased lipolysis, but also impaired β-adrenergic signaling-stimulated thermogenesis. The goal of this study is to define the mechanisms governing the whole process. Based on our preliminary observations, we hypothesize that the LD-targeting Ces3 generates fatty acids (FFA) “third messenger” that serve as specific PPARγ ligand(s) to trigger thermogenesis in adipose tissue. To test this hypothesis, we propose three specific Aims. In Aim 1, we will study the mechanism(s) by which Ces3 translocates onto LDs. We will first determine how cAMP-PKA signaling regulates the translocalization of Ces3 onto LDs. Then, we will investigate the role of Perilipin-1 in the translocalization of Ces3 onto LDs. In Aim 2, we will study the function of FFAs generated by Ces3 on thermogenesis. For this Aim, our preliminary results reveal that circulating Docosahexaenoic acid (DHA, C22:6 n=3), an established PPARγ ligand, is dramatically decreased in adipose tissue-specific Ces3 knockout mice. Our study will thus focus on a signaling mechanism that underlie the production of DHA - a key endogenous PPARγ ligand by Ces3. We will first confirm production of DHA by Ces3 in vitro and test whether DHA level is increased by β-adrenergic signaling-stimulation. Then we will detect whether DHA bound to PPARγ is increased as well. Finally, we will characterize the functions of DHA produced by Ces3. In Aim 3, we will assess the dysregulation of lipid metabolism in Ces3-deficient adipocytes. We will first exam the changes of lipid productions including DHA upon loss-of-function of Ces3. We will inhibit Ces3 activity by both pharmacological and genetic tools and assess the changes of free fatty acids (FFA) by quantitative lipidomics. Meanwhile, we will test the effects on the PPARγ transcriptional activity and UCP-1 mediated thermogenic program. Then, we will study the dysregulation of LDs at the absence of Ces3 in adipocytes. Particularly, we will exam the morphological changes of the cytosolic LDs upon Ces3 ablation. We will further test how the classical lipase axis ATGL-HSL-MGL is affected. The proposed study aims to elucidate a novel pathway that links lipid metabolism to energy expenditure from the viewpoint of dynamic regulation of LDs. Our study will address the critical roles of Ces3 and its product DHA in regulation of metabolic homeostasis. Results from the investigation will highlight the great potential of these novel players for therapeutic application in obesity and obesity-associated diseases.
脂滴(LDs)是胞质细胞器,在大多数细胞类型中充当主要的能量储存器。 中性脂质在脂肪组织LD中的过度积累与肥胖和肥胖相关的代谢紊乱有关。LD是动态形成的,扩大以及收缩和动力学是由多种蛋白质结合到其表面调节。最近,我们鉴定了羧酸酯酶3(Ces 3),其响应于β-肾上腺素能信号刺激而易位到LD表面。我们发现,阻断LD上的Ces 3不仅导致脂解减少,而且还损害了β-肾上腺素能信号刺激的产热作用。本研究的目的是确定整个过程的机制。基于我们的初步观察,我们假设LD靶向Ces 3产生脂肪酸(FFA)“第三信使”,其作为特异性PPARγ配体触发脂肪组织中的产热。为了验证这一假设,我们提出了三个具体目标。在目标1中,我们将研究Ces 3易位到LD上的机制。我们将首先确定cAMP-PKA信号如何调节Ces 3在LD上的转位。然后,我们将研究Perilipin-1在Ces 3转定位到LD中的作用。目的2:研究Ces 3产生的游离脂肪酸在产热过程中的作用。对于这个目标,我们的初步结果显示, 循环中的二十二碳六烯酸(DHA,C22:6 n=3),一种公认的PPARγ配体, 在脂肪组织特异性Ces 3敲除小鼠中降低。因此,我们的研究将集中在一个信号传导机制,基础上的生产DHA -一个关键的内源性PPARγ配体的Ces 3。我们将首先在体外证实Ces 3产生DHA,并测试DHA水平是否因β-肾上腺素能信号刺激而增加。然后我们将检测DHA与PPARγ结合是否也增加。最后,我们将描述由Ces 3产生的DHA的功能。在目标3中,我们将评估Ces 3缺陷脂肪细胞中脂质代谢的失调。我们将首先检查Ces 3功能丧失后脂质产生的变化,包括DHA。我们将通过药理学和遗传学工具抑制Ces 3活性,并通过定量脂质组学评估游离脂肪酸(FFA)的变化。同时,我们还将检测其对PPARγ转录活性和UCP-1介导的产热程序的影响。然后,我们将研究脂肪细胞中Ces 3缺失时LD的失调。特别地,我们将检查Ces 3消融后胞质LD的形态学变化。我们将进一步测试经典脂肪酶轴ATGL-HSL-MGL如何受到影响。 该研究旨在从LD动态调节的角度阐明一种将脂质代谢与能量消耗联系起来的新途径。我们的研究将解决Ces 3及其产物DHA在调节代谢稳态中的关键作用。调查结果将突出显示这些新型参与者在肥胖和肥胖相关疾病治疗应用中的巨大潜力。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Kai Sun其他文献

Kai Sun的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Kai Sun', 18)}}的其他基金

CO-LEADER: Intervention to Improve Patient-Provider Communication and Medication Adherence among Patients with Systemic Lupus Erythematosus
共同领导者:改善系统性红斑狼疮患者的医患沟通和药物依从性的干预措施
  • 批准号:
    10772887
  • 财政年份:
    2023
  • 资助金额:
    $ 23.4万
  • 项目类别:
Discovering the new function of DRP1 on lipid metabolism
发现DRP1对脂质代谢的新功能
  • 批准号:
    10445851
  • 财政年份:
    2022
  • 资助金额:
    $ 23.4万
  • 项目类别:
Discovering the new function of DRP1 on lipid metabolism
发现DRP1对脂质代谢的新功能
  • 批准号:
    10618321
  • 财政年份:
    2022
  • 资助金额:
    $ 23.4万
  • 项目类别:
Dichotomous Effects of MT1-MMP on Adipose Tissue Remodeling
MT1-MMP 对脂肪组织重塑的二分效应
  • 批准号:
    10448990
  • 财政年份:
    2017
  • 资助金额:
    $ 23.4万
  • 项目类别:
Dichotomous Effects of MT1-MMP on Adipose Tissue Remodeling
MT1-MMP 对脂肪组织重塑的二分效应
  • 批准号:
    9310794
  • 财政年份:
    2017
  • 资助金额:
    $ 23.4万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 23.4万
  • 项目类别:
    Fellowship
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 23.4万
  • 项目类别:
    Continuing Grant
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 23.4万
  • 项目类别:
    Research Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 23.4万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 23.4万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 23.4万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 23.4万
  • 项目类别:
    EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 23.4万
  • 项目类别:
    Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 23.4万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 23.4万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了